Great synergy sales... Also:
" In October 2015, Admedus also initiated a post-market clinical study using CardioCel to reconstruct aortic valves in 80 patients across four leading heart centres in the US and Europe. The study is designed to illustrate the utility and benefits of CardioCel in aortic valve reconstruction over valve replacements. Patients in the clinical study will be reviewed 6, 12 and 24 months post-surgery to evaluate safety data and primary and secondary endpoints"
The 6 months period is up in April, does that mean we will get an update after the first evaluation for the aortic valve reconstruction with cardiocel? Should be around the corner... Worth a question to Mr Chick
Ann: CORONEO Australia New Zealand Distribution Partnership-AHZ.AX, page-2
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
0.140(1.08%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.50 | $13.14 | $559.5K | 42.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1180 | $13.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.35 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |